Huina Liu

Dr. Huina Liu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2020 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
ZFZhipeng Fan
Zhipeng Fan
YCYangyang Cao
Yangyang Cao
JZJianpeng Zhang
Jianpeng Zhang
YLYuncun Liang
Yuncun Liang
XSXiaomin Su
Xiaomin Su
ZFZhipeng Fan
Zhipeng Fan
Background: Mesenchymal stem cell (MSC)-based cartilage tissue regeneration is a treatment with great potential. How to enhance the MSC chondrogenic differentiation is a key issue involved in cartilage formation. In the present study, we seek to expound the phenotypes and mechanisms of DLX5 in chondrogenic differentiation function in MSCs.Methods: Stem cells from apical papilla (SCAPs) were used. The Alcian Blue staining, pellet culture system, and cell transplantation in rabbit knee cartilage defect were used to evaluate the chondrogenic differentiation function of MSCs. Western blot, real-time RT-PCR, and ChIP assays were used to evaluate the molecular mechanisms.Results: DLX5 and HOXC8 expressions were upregulated during chondrogenic differentiation. In vitro results showed that DLX5 and HOXC8 enhanced the expression of chondrogenic markers including collagen II (COL2), collagen V (COL5), and sex-determining region Y box protein 9 (SOX9) and promoted the chondrogenic differentiation and the formation of cartilage clumps in the pellet culture system. Mechanically, DLX5 and HOXC8 formed protein complexes and negatively regulated the LncRNA, LINC01013, via directly binding its promoter. In vivo transplantation experiment showed that DLX5 and HOXC8 could restore the cartilage defect in the rabbit knee model. In addition, knock-down of LINC01013 enhanced the chondrogenic differentiation of SCAPs.Conclusions: In conclusion, DLX5 and HOXC8 enhance the chondrogenic differentiation abilities of SCAPs by negatively regulating LINC01013 in SCAPs, and provided the potential target for promoting cartilage tissue regeneration.

18 June 2024 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
HLHua Liu
Hua Liu
HLHuina Liu
Huina Liu
QYQiubo Yang
Qiubo Yang
ZFZhipeng Fan
Zhipeng Fan
Background: Cartilage is a kind of avascular tissue, and it is difficult to repair itself when it is damaged. In this study, we investigated the regulation of chondrogenic differentiation and vascular formation in human jaw bone marrow mesenchymal stem cells (h-JBMMSCs) by the long-chain noncoding RNA small nucleolar RNA host gene 1 (SNHG1) during cartilage tissue regeneration. Methods: JBMMSCs were isolated from the jaws via the adherent method. The effects of lncRNA SNHG1 on the chondrogenic differentiation of JBMMSCs in vitro were detected by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR), Pellet experiment, Alcian blue staining, Masson’s trichrome staining, and modified Sirius red staining. RT-qPCR, matrix gel tube formation, and coculture experiments were used to determine the effect of lncRNA SNHG1 on the angiogenesis in JBMMSCs in vitro. A model of knee cartilage defects in New Zealand rabbits and a model of subcutaneous matrix rubber suppositories in nude mice were constructed for in vivo experiments. Changes in mitochondrial function were detected via RT-qPCR, dihydroethidium (DHE) staining, MitoSOX staining, tetramethyl rhodamine methyl ester (TMRM) staining, and adenosine triphosphate (ATP) detection. Western blotting was used to detect the phosphorylation level of signal transducer and activator of transcription 3 (STAT3). Results: Alcian blue staining, Masson’s trichrome staining, and modified Sirius Red staining showed that lncRNA SNHG1 promoted chondrogenic differentiation. The lncRNA SNHG1 promoted angiogenesis in vitro and the formation of microvessels in vivo. The lncRNA SNHG1 promoted the repair and regeneration of rabbit knee cartilage tissue. Western blot and alcian blue staining showed that the JAK inhibitor reduced the increase of STAT3 phosphorylation level and staining deepening caused by SNHG1. Mitochondrial correlation analysis revealed that the lncRNA SNHG1 led to a decrease in reactive oxygen species (ROS) levels, an increase in mitochondrial membrane potential and an increase in ATP levels. Alcian blue staining showed that the ROS inhibitor significantly alleviated the decrease in blue fluorescence caused by SNHG1 knockdown. Conclusions: The lncRNA SNHG1 promotes chondrogenic differentiation and angiogenesis of JBMMSCs. The lncRNA SNHG1 regulates the phosphorylation of STAT3, reduces the level of ROS, regulates mitochondrial energy metabolism, and ultimately promotes cartilage regeneration.

10 September 2026 in International Dental Journal
Verified
Journal Article
Open access
DSDong Shuangshan
Dong Shuangshan
ZSZiyan Sun
Ziyan Sun
JSJiajian Shang
Jiajian Shang
HLHuina Liu
Huina Liu
ZFZhipeng Fan
Zhipeng Fan
Functional tooth regeneration remains a major challenge in clinical dentistry and depends on the precise odontogenic/osteogenic commitment of resident stem cells. Micro-peptides encoded by long noncoding RNAs represent a novel source of bioactive molecules for regenerative therapy. This study aimed to investigate whether a newly identified 76-amino acid micro-peptide, PLXDC2-OT-peptide, promotes odontogenic/osteogenic differentiation of stem cells from the apical papilla (SCAPs) and to clarify its underlying mechanism. The biological effects of PLXDC2-OT-peptide were evaluated in SCAPs using in vitro assays for biocompatibility, cell migration, mineralisation and odontogenic/osteogenic marker expression. Three-dimensional organoid culture was used to assess matrix maturation, and an in vivo model was established to examine dentin-like tissue formation over 12 weeks. RNA sequencing and bioinformatic enrichment analyses were performed to identify peptide-regulated genes and signalling pathways. Mechanistic validation was conducted to determine the involvement of the PI3K-AKT signalling pathway. PLXDC2-OT-peptide showed favourable biocompatibility and significantly enhanced SCAP migration, mineralised nodule formation and the expression of odontogenic/osteogenic markers, including DSPP, DMP1, RUNX2 and OCN. The peptide also promoted extracellular matrix maturation in 3D organoids and induced dentin-like tissue formation in vivo. Transcriptomic analysis identified 330 upregulated and 338 downregulated genes following peptide treatment. Enrichment analyses revealed marked changes in growth factor binding and cell cycle-related pathways, with PI3K-AKT signalling emerging as a key pathway. Mechanistic experiments confirmed that PLXDC2-OT-peptide promoted odontogenic/osteogenic differentiation of SCAPs through activation of the PI3K-AKT signalling pathway. PLXDC2-OT-peptide is a novel lncRNA-encoded micro-peptide that enhances odontogenic/osteogenic differentiation of SCAPs and promotes dentin-like tissue regeneration, at least partly through PI3K-AKT signalling activation. PLXDC2-OT-peptide may serve as a promising synthetic therapeutic candidate for dental defect repair and regenerative endodontic applications.